Massive bladder cancer study to reveal Real-World treatment outcomes

NCT ID NCT07386847

Not yet recruiting Knowledge-focused Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Feb 04, 2026 · Last updated May 11, 2026 · Updated 11 times

Summary

This study will look at medical records from 3,000 adults with advanced bladder cancer to see how long their first treatment keeps the disease from getting worse. Researchers will also track which medicines doctors actually prescribe. This is not a new treatment trial—it simply observes what happens during routine care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.